Description

n-{3-[Benzyl(3-Pyridinylcarbonyl)Amino]Propyl}-4-Oxo-3,4-Dihydro-2-Quinazolinecarboxamide is a high-purity, synthetic organic compound belonging to the quinazoline class, designed for advanced research and development applications. This compound is valued for its role as a key intermediate or active pharmaceutical ingredient (API) in the development of novel therapeutic agents. It is primarily sought by pharmaceutical R&D teams, biotechnology firms, and academic research institutions focused on medicinal chemistry and drug discovery.

Application

• Pharmaceutical Research: Serves as a critical intermediate or building block in the synthesis of novel drug candidates targeting various disease pathways.
• Medicinal Chemistry: Used in structure-activity relationship (SAR) studies and lead optimization processes for new therapeutic agents.
• Biochemical Research: Employed as a reference standard or tool compound in enzyme inhibition assays and biological target validation.
• API Development: Functions as a key starting material (KSM) or advanced intermediate in the multi-step synthesis of Active Pharmaceutical Ingredients (APIs).
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for pharmaceutical clients.
• Academic Research: Utilized in university and institutional labs for fundamental research in organic synthesis and pharmacology.

Basic Information

Product Name	n-{3-[Benzyl(3-Pyridinylcarbonyl)Amino]Propyl}-4-Oxo-3,4-Dihydro-2-Quinazolinecarboxamide
CAS No.	1119398-31-0
Molecular Formula	C25H23N5O3
Molecular Weight	441.48 g/mol
Synonyms	N-[3-[Benzyl(pyridine-3-carbonyl)amino]propyl]-4-oxo-3,4-dihydroquinazoline-2-carboxamide; 4-Oxo-N-[3-[phenylmethyl(3-pyridinylcarbonyl)amino]propyl]-3,4-dihydro-2-quinazolinecarboxamide; 1119398-31-0; UNII-9H2C4F7J9U; 9H2C4F7J9U; Quinazolinecarboxamide derivative; BZP-4-Oxo-3,4-Dihydro-2-QC
EINECS	Contact for details

Quality Control

Our n-{3-[Benzyl(3-Pyridinylcarbonyl)Amino]Propyl}-4-Oxo-3,4-Dihydro-2-Quinazolinecarboxamide is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, MS), to ensure compliance with exacting research-grade standards. A comprehensive Certificate of Analysis (COA) detailing purity, assay, and impurity profiles is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) in a dry, well-ventilated area. The compound may be hygroscopic (moisture-sensitive); keep the container tightly sealed in a desiccated environment to maintain stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference standard
Purity (HPLC)	≥ 98.0%
Assay	97.0% - 102.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.